Versant Capital Management
TYRA icon

Versant Capital Management’s Tyra Biosciences TYRA Stock Holding History

Versant Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.9K Hold
819
– – ﹤0.01% 2020
2026
Q2 		$26.2K Hold
819
– – ﹤0.01% 1791
2026
Q1 		$31.4K Hold
819
– – ﹤0.01% 1540
2025
Q4 		$21.5K Hold
819
– – ﹤0.01% 1593
2025
Q3 		$11.5K Hold
819
– – ﹤0.01% 1874
2025
Q2 		$7.84K Buy
+819
New +$7.78K ﹤0.01% 1994

Other funds holding TYRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Versant Capital Management's TYRA Position: Q3 2026 in Review

Versant Capital Management held its Tyra Biosciences (TYRA) position steady in Q3 2026 at 819 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Versant Capital Management first reported a position in TYRA in Q2 2025 and has held it in 6 quarters since. The position peaked at $31.4K in Q1 2026. 44 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Versant Capital Management held 819 shares of Tyra Biosciences worth $17.9K as of Q3 2026.
  • Versant Capital Management left its Tyra Biosciences share count unchanged in Q3 2026.
  • Tyra Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2020 holding.
  • Versant Capital Management first reported a position in Tyra Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Versant Capital Management's Tyra Biosciences position peaked at $31.4K in Q1 2026.
  • 44 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.